Sedana Medical Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Sedana Medical (STO:SEDANA) Full Year 2023 Results

Key Financial Results

• Revenue: kr153.9m (up 25% from FY 2022).
• Net loss: kr59.6m (loss narrowed by 19% from FY 2022).
• kr0.60 loss per share (improved from kr0.74 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sedana Medical Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 38%.

Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's shares are down 1.6% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Sedana Medical's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.